Metabolic remission with octreotide in patients with insulinoma
- 1 March 1994
- journal article
- clinical trial
- Published by Wiley in Journal of Internal Medicine
- Vol. 235 (3), 245-248
- https://doi.org/10.1111/j.1365-2796.1994.tb01067.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Gastrointestinal Side-Effects of Octreotide during Long Term Treatment of Acromegaly*Journal of Clinical Endocrinology & Metabolism, 1990
- OctreotideDrugs, 1989
- Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin®)Acta Endocrinologica, 1989
- Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the GutAnnals of Internal Medicine, 1989
- Radioimmunological determination of human C-peptide in serumDiabetologia, 1975